Clinical Assessments and Care for Female Pattern Hair Loss

Dr Rahma Targett
General Practitioner (FRACGP)

Female pattern hair loss, or FPHL, is the most prevalent cause of hair thinning in women globally. This condition is clinically referred to as androgenetic alopecia and follows a distinct progression compared to hair loss in men.

At StranDr Adelaide, we recognize that hair thinning can be a deeply personal experience. Our approach centers on evidence-based clinical assessments to identify the underlying cause and provide a clear management plan.

The Clinical Presentation of FPHL

Unlike the receding hairlines often seen in men, FPHL typically presents as a diffuse thinning across the mid-scalp. The frontal hairline usually remains intact, which can sometimes delay an initial diagnosis.

The first sign many women notice is a visible widening of the “part” line. Over time, the scalp may become more visible through the hair, particularly under bright lights.

Clinical observations often identify the following characteristics:

  • The Christmas Tree Pattern: This involves thinning that is most pronounced at the front of the scalp and tapers off toward the crown.
  • Reduction in Volume: Patients frequently report a noticeable decrease in ponytail thickness or hair volume.
  • Miniaturization: Healthy hair follicles are gradually replaced by finer, shorter hairs that provide less coverage.
  • Scalp Visibility: Increased spacing between individual hairs across the top of the head.

Clinical Staging and Classification

To monitor the progression of thinning and the effectiveness of any intervention, clinicians use standardized grading systems. The Savin Scale is the most common tool used to categorize the density of hair on the crown.

Understanding these stages helps both the clinician and the patient set realistic expectations for hair restoration. The scale provides a visual reference for the density of the mid-scalp region.

Savin Stage Clinical Description
Stage I Perceptible thinning of the hair on the crown with a slightly wider part.
Stage II Pronounced thinning where the part line is significantly wider and density is reduced.
Stage III Extensive thinning across the top of the scalp with high scalp visibility.

The Diagnostic Process at StranDr Adelaide

A formal diagnosis is a critical first step because hair thinning can be a symptom of various internal medical issues. We must rule out conditions like thyroid dysfunction, iron deficiency, or autoimmune disorders before proceeding.

Our clinical assessment involves several specialized diagnostic techniques to ensure accuracy. These tools allow us to view the scalp and follicles in ways that are not possible with the naked eye.

Trichoscopy and Digital Imaging

We use a specialized dermatoscope to perform trichoscopy, which examines the scalp at high magnification. This allows us to confirm the presence of miniaturized hairs and assess the health of the scalp skin.

By capturing these images, we can establish a baseline for your hair density. This data is vital for tracking your progress over several months of care.

The Clinical Hair Pull Test

A hair pull test is a standard bedside procedure used to determine if hair shedding is currently active or stable. The clinician gently pulls a small group of hairs to see how many are released from the follicle.

In cases of pure FPHL, the pull test is typically negative. A positive test may suggest an additional condition, such as telogen effluvium, which requires a different management approach.

Pathology and Blood Analysis

If indicated during your consultation, we may refer you for blood tests to screen for underlying triggers. Hormonal imbalances, such as those found in Polycystic Ovary Syndrome (PCOS), can significantly influence hair loss.

Nutritional deficiencies in iron, zinc, or vitamin D are also common contributors to reduced hair quality. Addressing these systemic factors is often necessary to support the health of the hair follicles.

Evidence-Based Management Options

Managing FPHL requires a long-term strategy focused on stabilization and, where possible, increasing hair density. There are several pathways available, ranging from topical applications to surgical hair restoration.

It is important to note that results vary between individuals and no outcome can be assured. All medical and surgical interventions carry potential risks that must be discussed during a clinical consultation.

  • Topical Therapy: Clinical formulations designed to prolong the growth phase of the hair follicle.
  • Oral Medications: Prescription options that address hormonal influences on the scalp, which require ongoing medical supervision.
  • Non-Surgical Interventions: Techniques aimed at managing hair loss without surgery to improve scalp health.
  • FUE Hair Transplant: A surgical option where healthy follicles are relocated to areas of thinning for eligible candidates.

Is an FUE Hair Transplant Suitable?

For some women, a surgical FUE hair transplant may be a viable option to restore density in specific areas. This procedure involves extracting individual follicular units from a donor site and implanting them into the thinning regions.

Determining if you are a good candidate depends on several clinical factors. These include the stability of your hair loss and the density of your donor hair at the back of the scalp.

Surgery is not a first-line treatment for FPHL and is only considered after medical management has been explored. A comprehensive assessment at our clinic for a hair transplant Adelaide will determine the most appropriate course of action.

What to Expect from Treatment

Hair growth is a slow physiological process, and any intervention requires patience. Most patients will not see a visible change for at least three to six months after beginning a new regimen.

The primary goal of most treatments is to stop the progression of thinning. While some women experience regrowth, the main objective is often to maintain existing hair and prevent further loss.

Consistent adherence to the prescribed plan is essential for long-term success. If treatment is discontinued, the hair thinning will typically resume its natural progression over time.

Clinical Note: All medical and surgical procedures involve risks, including infection, scarring, or side effects from medications. It is essential to review these risks in accordance with AHPRA guidelines before making an informed decision about your care.

Why a Professional Consultation Matters

Self-diagnosing hair loss can lead to the use of ineffective over-the-counter products that do not address the root cause. A clinical environment provides access to diagnostic equipment and medical expertise that is not available elsewhere.

During a consultation, we take the time to review your medical history, perform a physical examination, and discuss your goals. This ensures that any recommendation is tailored specifically to your clinical needs. For additional information on hair loss conditions and treatment options, you may find resources from healthdirect helpful.

A professional assessment also ensures that you are aware of the limitations of each treatment option. We prioritize transparency and clinical integrity in every patient interaction.

If you are concerned about hair thinning and would like to understand your options, the first step is a professional evaluation. Contact StranDr to book a clinical consultation with our experienced team in Adelaide.

Mandatory Risk Disclosure: All surgical and non-surgical cosmetic procedures carry risks. A hair transplant is an invasive procedure that requires a recovery period and may lead to complications such as infection, scarring, or anesthesia reactions. Results vary for each individual and are not guaranteed. A thorough clinical consultation is required to determine if this procedure is suitable for your specific medical needs.